-
Razpipadon (developmental
codes CVL-871, PF-06669571, and PW-0464) is a
dopamine receptor agonist which is
under development for the
treatment of dementia-related...
- A-86929, adrogolide, dihydrexidine, dinapsoline, doxanthrine, fenoldopam,
razpipadon, SKF-81,297, SKF-82,958, SKF-89,145, tavapadon, and trepipam. They have...
-
phase 3
clinical trials for Parkinson's disease.
Mevidalen (LY-3154207)
Razpipadon (CVL-871)
Bezard E, Gray D,
Kozak R,
Leoni M,
Combs C,
Duvvuri S (2024)...
-
Centrally acting dopamine D1-like
receptor agonists like
tavapadon and
razpipadon and D1
receptor positive modulators like
mevidalen and
glovadalen are...
- like
amphetamine and
lisdexamfetamine Dopamine D1
receptor agonists like
razpipadon Dopamine precursors like
levodopa (L-DOPA)
Catecholaminergic activity...
-
attention deficit hyperactivity disorder (ADHD).
Glovadalen (UCB-0022)
Razpipadon (CVL-871)
Tavapadon (CVL-751) "Mevidalen - Eli
Lilly and Company". AdisInsight...
